Encore PFO Closure Device - The PerFOrm Trial

NARecruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

July 12, 2023

Primary Completion Date

April 30, 2026

Study Completion Date

October 31, 2030

Conditions
Patent Foramen OvaleCryptogenic Stroke
Interventions
DEVICE

Encore PFO closure device

The Encore PFO closure device comprises an implant component and a single-use delivery system.

DEVICE

FDA-approved PFO closure device

Chosen by the investigator

Trial Locations (8)

29425

RECRUITING

Medical University of South Carolina Gazes Research Institute, Charleston

33606

RECRUITING

University of South Florida, Tampa

39216

RECRUITING

Jackson Heart Clinic, Jackson

50266

RECRUITING

Mercy One Iowa Heart Center, West Des Moines

66160

RECRUITING

Kansas University Medical Center, Kansas City

68124

RECRUITING

CHI Health, Omaha

72205

RECRUITING

Arkansas Cardiology, Little Rock

92037

RECRUITING

Southern CA Permanente Medical Group - Kaiser San Diego and Scripps Memorial Hospital, La Jolla

Sponsors
All Listed Sponsors
collaborator

Bright Research Partners

INDUSTRY

collaborator

Yale Cardiovascular Research Group

OTHER

lead

Encore Medical Inc.

INDUSTRY